Sporotrichosis

ICD-11

1F2J.Z; 1F2J.0; 1F2J.1

Synonyms

Lymphocutaneous and fixed cutaneous sporotrichosis.

Epidemiology

Worldwide distribution. Preferentially in areas with warm, humid, tropical or subtropical climates (Africa, Asia, South America). Young adults is the preferred age group; children are rarely affected.

Definition

Sporotrichosis is a polymorphic subacute or chronic infection by dimorphic fungi of the Sporothrix schenckii complex, which includes several phylogenetically distinct species of dimorphic fungi.

Aetiology & Pathogenesis

Through injury or wounds, inoculation of soil, plants, and decaying material, contaminated with the fungus of the Sporothrix schenckii complex in florists (“Gardner’s disease”). The respiratory route is less common. Transmission also may occur by various animals (rodents). There are various forms of manifestation (see classification). Average incubation time is three weeks. The risk of disseminated disease is increased in immunocompromised patients, or in patients with chronic obstructive pulmonary disease, alcohol abuse, and diabetes.

Signs & Symptoms

Sporotrichosis mostly presents in its cutaneous-lymphatic (>90%) form, with papules, pustules, or linearly distributed, painful or pruriginous ulcerated nodules (chancre), which may develop verrucous plaques in chronic forms and spread along lymphatic vessels.

The second form is cutaneous-fixed sporotrichosis (30% of cases) , which occurs in the same inoculation site (called sporotrichoid chancre), usually consisting of an asymptomatic, sole, vegetative, or slow-growing verrucous lesion, and a squamous, erythematous or violaceous halo

The cutaneous-disseminated (hematogenous ) sporotrichosis is reported in up to 8% of cases and is usually seen in immunocompromised patients. It can manifest at any part of the body surface, and involve even mucous membranes, bones and joints, producing small granulomatous or extensive lytic lesions and osteomyelitis, associated with joint effusions, edema and severe pain.

The extracutaneous forms are less commonly seen, and include disseminated sporotrichosis, pulmonary sporotrichosis and various osteoarticular, ocular and central nervous system disorders.

Localisation

Upper and lower limbs and face.

Classification

Sporotrichosis is classified into cutaneous, pulmonary, and disseminated, with cutaneous being the most common form of the disease (see symptoms).

Laboratory & other workups

Cultures (5 and 8 days; Sabouraud dextrose agar) from exudative lesions, scale, tissue fragment, sputum and blood.

Detection of “cigar-shaped” yeast elements (scarce in cutaneous-lymphatic forms; better to be seen in cutaneous-disseminated or pulmonary, using PAS or Grokott staining). The two main causative agents are Sporothrix schenckii and Sporothrix brasiliensis. Species recognition by Polymerase Chain Reaction.

Dermatopathology

Suppurative granulomas with scarce yeasts and asteroid bodies (PAS and Grocott stains). It must be distinguished from histoplasmosis.

Course

Chronic spread and dissemination.

Complications

Involvement of extracutaneous organs (see symptoms).

Diagnosis

Clinically (“sporotrichoid”) spread along lymphatic vessels.

Differential diagnosis

Cutaneous Leishmaniasis, histoplasmosis, psoriasis.

Prevention & Therapy

Prevention of trauma.

Cutaneous-lymphatic and cutaneous-fixed sporotrichosis: potassium iodide in diluted solutions.Drug of choice for both clinical forms: itraconazole at 200 mg/day for 3–6 months.

Cutaneous-disseminated, disseminated, pulmonary and osteoarticular sporotrichosis: amphotericin B, 3–5 mg/kg/day.

Special

Cave: confusion with histoplasmosis.

10.2.2 Sporotrichosis